Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01164163
Title INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Children's Oncology Group|National Cancer Institute (NCI)
Indications

myelodysplastic/myeloproliferative neoplasm

childhood leukemia

Advanced Solid Tumor

Therapies

Ruxolitinib

Age Groups: child
Covered Countries USA

Additional content available in CKB BOOST